Incyte Corp (NAS:INCY)
$ 57.05 -0.55 (-0.95%) Market Cap: 12.83 Bil Enterprise Value: 9.14 Bil PE Ratio: 17.29 PB Ratio: 2.38 GF Score: 88/100

Incyte Corp at Cowen Health Care Conference (Virtual) Transcript

Mar 07, 2022 / 02:50PM GMT
Release Date Price: $70.62 (+0.81%)
Marc Alan Frahm
Cowen and Company, LLC, Research Division - Director

All right. Welcome back to the next session of the Cowen Healthcare Conference, where we're really pleased to have the team from Incyte with us. And joining the IR team, Christine and Greg in the room there as well as CMO, Steven Stein; and CFO, Christiana Stamoulis.

And I remind everyone, you can -- I have a list of questions and I will walk through with them, but also would love to make this interactive today as possible. So please submit questions to me at [email protected] or through the chat function in the webcast, either route is fine, and then I will pepper those questions in as well..

So maybe just to start off, we will turn to Christiana Stamoulis. Christiana, can you just kind of level set everybody with just high-level update from the earnings report and kind of what you think the takeaways are moving forward, and then we can get into some of the specific questions.

Christiana Stamoulis
Incyte Corporation - Executive VP & CFO

Yes, absolutely. I can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot